Is Indrayani Biotech a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Indrayani Biotech Ltd is a average quality company .

Is Indrayani Biotech undervalued or overvalued?

The key valuation ratios of Indrayani Biotech Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Indrayani Biotech share price return in the past 10 years?

Indrayani Biotech Ltd share price has appreciated 28.7% annually (CAGR) over the past ten years.

Is Indrayani Biotech a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Indrayani Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Indrayani Biotech Ltd - Stock Valuation and Financial Performance

Name: Indrayani Biotech
Brand: Indrayani Biotech

BSE: 526445 | NSE: | Floriculture | Small Cap

Place order

Indrayani Biotech Share Price

₹60.50 2.66 4.60%
as on 16-Apr'24 09:58

10 Year X-Ray of Indrayani Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	-2%	-2.9%	-3.7%	-5.9%	6,826.7%	732.2%	186.4%	-37.7%	14.6%	11.6%	-
Value Creation Index ⓘ	-1.1	-1.2	-1.3	NA	NA	NA	NA	-3.7	0.0	-0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0.5	21	58	74.5	68
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	4,102%	176%	28.4%	-
Adj EPS ⓘ	-0.2	-0.3	-0.4	-0.3	-0.3	-0.2	-0.6	-2.3	1.2	1.6	0.5
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	28.5%	-
BVPS (₹) ⓘ	9.2	8.9	8.6	-1.3	-1.7	-1.8	-2.4	5.8	7.1	11.8	12.9
Adj Net Profit ⓘ	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.2	-8	4.2	5.4	2
Cash Flow from Ops. ⓘ	-0.1	-0.1	-0.1	-0.1	-0.1	-0.2	0.1	0.5	3.5	8.3	-
Debt/CF from Ops. ⓘ	-2.2	-2.9	-3	-4.6	-5.1	-3.1	8.7	29.8	4.8	4.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	430.1%	28.4%
Adj EPS ⓘ	NA	NA	NA	28.5%
BVPSⓘ	2.8%	NA	NA	67%
Share Price	28.7%	60.2%	113.2%	-13.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	-2.1	-3.1	-4.1	-7.8	23	8.6	27.1	-83.9	19.2	14.4	4.1
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	-30.8	-22.2	10.8	11.7	10.5
Net Profit Mgn % ⓘ	0	0	0	0	0	0	-41	-38.1	7.3	7.3	3.4
Debt to Equity ⓘ	0	0.1	0.1	-1	-1	-1	-0.8	0.8	0.7	0.7	-
Working Cap Days ⓘ	0	0	0	0	0	0	49	90	93	182	164
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	-101	22	28	56	67

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 4.10%

Sales growth is growing at healthy rate in last 3 years 430.10%

Debt to equity has declined versus last 3 years average to 0.71

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 3.88%

Latest Financials - Indrayani Biotech Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.5	1.1
TTM Sales (₹ Cr.)	67.8	171
BVPS (₹.) ⓘ	12.9	14.2
Reserves (₹ Cr.) ⓘ	13	19
P/BV ⓘ	4.49	4.06
PE ⓘ	116.64	53.57

From the Market
52 Week Low / High (₹)	46.80 / 99.70
All Time Low / High (₹)	0.50 / 115.70
Market Cap (₹ Cr.)	263
Equity (₹ Cr.)	45.5
Face Value (₹)	10
Industry PE ⓘ	74.7

Management X-Ray of Indrayani Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

14.98

* Pledged shares as % of Promoter's holding (%)

Valuation of Indrayani Biotech

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Indrayani Biotech

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0	0	0	0	0	0	1	21	58	74
Operating Expenses ⓘ	0	0	0	0	0	0	1	26	52	66
Manufacturing Costs	0	0	0	0	0	0	0	0	0	1
Material Costs	0	0	0	0	0	0	0	16	40	41
Employee Cost	0	0	0	0	0	0	0	5	8	17
Other Costs ⓘ	0	0	0	0	0	0	0	4	3	7
Operating Profit ⓘ	0	0	0	0	0	0	0	-5	6	9
Operating Profit Margin (%)	-	-	-	-	-	-	-30.8%	-22.2%	10.8%	11.7%
Other Income ⓘ	0	0	0	0	0	0	0	0	0	1
Interest ⓘ	0	0	0	0	0	0	0	2	2	3
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	-4	0	-1
Profit Before Tax ⓘ	0	0	0	0	0	0	0	-11	4	5
Tax ⓘ	0	0	0	0	0	0	0	0	0	0
Profit After Tax	0	0	0	0	0	0	0	-11	4	5
PAT Margin (%)	-	-	-	-	-	-	-41.0%	-51.8%	7.3%	6.8%
Adjusted EPS (₹)	-0.2	-0.3	-0.4	-0.3	-0.3	-0.2	-0.6	-3.2	1.2	1.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	3	3	3	0	-1	-1	-1	20	24	50
Share Capital ⓘ	4	4	4	4	4	4	4	34	34	43
Reserves ⓘ	0	0	-1	-4	-4	-4	-5	-14	-10	6
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	1	1	1	15	17	34
Long Term Debt	0	0	0	0	1	1	1	8	7	10
Short Term Debt	0	0	0	0	0	0	0	7	10	24
Trade Payables	0	0	0	0	0	0	0	3	6	2
Others Liabilities ⓘ	0	0	0	0	0	0	0	1	2	15
Total Liabilities ⓘ	4	4	4	0	0	0	0	40	49	100
Fixed Assets
Gross Block	4	3	3	0	0	0	0	17	17	26
Accumulated Depreciation	0	0	0	0	0	0	0	1	2	3
Net Fixed Assetsⓘ	4	3	3	0	0	0	0	15	15	24
CWIP ⓘ	0	0	0	0	0	0	0	14	13	13
Investmentsⓘ	0	0	0	0	0	0	0	0	0	8
Inventories	0	0	0	0	0	0	0	1	1	2
Trade Receivables	0	0	0	0	0	0	0	5	13	16
Cash Equivalents	0	0	0	0	0	0	0	1	1	1
Others Assetsⓘ	0	0	0	0	0	0	0	4	5	37
Total Assets ⓘ	4	4	4	0	0	0	0	40	49	100

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0	1	3	8
PBT ⓘ	0	-11	4	5
Adjustment ⓘ	0	4	2	4
Changes in Working Capital ⓘ	-0	7	-3	-1
Tax Paid ⓘ	0	0	0	0
Cash Flow From Investing Activity ⓘ	0	-1	1	-14
Capex	0	0	0	-2
Net Investments	0	0	0	-8
Others ⓘ	0	0	1	-4
Cash Flow From Financing Activityⓘ	0	-1	-3	5
Net Proceeds from Shares ⓘ	0	0	0	22
Net Proceeds from Borrowing ⓘ	0	0	0	0
Interest Paid ⓘ	0	-2	-2	-2
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	0	1	-1	-15
Net Cash Flow ⓘ	0	-1	1	-1

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	-2.06	-3.06	-4.05	N/A	N/A	N/A	N/A	-114.06	19.15	15.67
ROCE (%)	-1.98	-2.88	-3.67	N/A	N/A	N/A	N/A	-50.65	16.03	12.45
Asset Turnover Ratio	0	0	0	0	0	0	4.44	1.05	1.3	0.99
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.75	1.6
Working Capital Days
Receivable Days	0	0	0	0	0	0	56	42	56	71
Inventory Days	0	0	0	0	0	0	0	19	8	8
Payable Days	0	0	0	0	0	0	142	44	45	35

Indrayani Biotech Ltd Stock News

Indrayani Biotech Ltd FAQs

What is the share price of Indrayani Biotech?

Company share prices are keep on changing according to the market conditions. The closing price of Indrayani Biotech on 16-Apr-2024 09:58 is ₹60.50.

What is the market cap of Indrayani Biotech?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2024 09:58 the market cap of Indrayani Biotech stood at ₹263.4.

What is the P/E ratio of Indrayani Biotech?

The latest P/E ratio of Indrayani Biotech as of 16-Apr-2024 09:58 is 116.6.

What is the P/B ratio of Indrayani Biotech?

The latest P/B ratio of Indrayani Biotech as of 16-Apr-2024 09:58 is 4.49.

What is the 52-week high and low of Indrayani Biotech?

The 52-week high of Indrayani Biotech is ₹99.70 and the 52-week low is ₹46.80.

What is the TTM revenue of Indrayani Biotech?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Indrayani Biotech is ₹67.83 ( Cr.) .

About Indrayani Biotech Ltd

The company was incorporated on March 9, 1992 and it was converted into a public limited company on March 13, 1992. It is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds.

Indrayani Biotech produces cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company has also started marketing and distribution and extensive field demonstrations of hybrid vegetable seeds manufactured by HOECHST India. Technical agreements have been signed with Floral Max, Malaysia for rose cultivation and with B. L. McKenzie and Associates, New Zealand for tissue culture. The planting material for strawberries has been acquired from the US. Indrayani Biotech has signed a test agreement with the technology transfer offer of the University of California to obtain certified planting material from nurseries in California.

Indrayani Biotech started exporting flowers to Holland and Dubai in 1994-1995. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals. In 1995-1996, the company incurred losses due to insufficient water supply, labor problems and sub-standard infrastructure. To overcome the above problems, the company is considering shifting its green houses to alternate locations.

The company has installed five Greenhouses and plantation in these greenhouses is complete. A pilot tissue culture laboratory is also completed and the protocol to be used in manufacture of tissue culture plantlets is being perfected.

The companyâ€™s registered office and factory are located at Pune, India.